Fractyl Health, Inc. Common StockGUTSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.6%
5Y CAGR+28.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+31.6%/yr
Annual compound
5Y CAGR
+28.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $78.32M | +11.1% |
| 2024 | $70.47M | +85.3% |
| 2023 | $38.04M | +10.7% |
| 2022 | $34.35M | +30.0% |
| 2021 | $26.43M | +17.8% |
| 2020 | $22.43M | +7.4% |
| 2019 | $20.89M | - |